156 related articles for article (PubMed ID: 11911727)
1. Aseptic meningitis associated with rofecoxib.
Bonnel RA; Villalba ML; Karwoski CB; Beitz J
Arch Intern Med; 2002 Mar; 162(6):713-5. PubMed ID: 11911727
[TBL] [Abstract][Full Text] [Related]
2. Recurrent aseptic meningitis due to different non-steroidal anti-inflammatory drugs including rofecoxib.
Ashwath ML; Katner HP
Postgrad Med J; 2003 May; 79(931):295-6. PubMed ID: 12782779
[TBL] [Abstract][Full Text] [Related]
3. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
Matheson AJ; Figgitt DP
Drugs; 2001; 61(6):833-65. PubMed ID: 11398914
[TBL] [Abstract][Full Text] [Related]
4. Rofecoxib: clinical pharmacology and clinical experience.
Weaver AL
Clin Ther; 2001 Sep; 23(9):1323-38. PubMed ID: 11589252
[TBL] [Abstract][Full Text] [Related]
5. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
Maetzel A; Krahn M; Naglie G
Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781
[TBL] [Abstract][Full Text] [Related]
6. Cognitive decline with chronic meningitis secondary to a COX-2 inhibitor.
Ashton D; Kim P; Griffiths N; Beran R
Age Ageing; 2004 Jul; 33(4):408-9. PubMed ID: 15151910
[TBL] [Abstract][Full Text] [Related]
7. Intracranial hypertension induced by rofecoxib.
Jacob S; Rajabally YA
Headache; 2005 Jan; 45(1):75-6. PubMed ID: 15663617
[TBL] [Abstract][Full Text] [Related]
8. [Pharma-clinics. The drug of the month. Rofecoxib (Vioxx)].
Scheen AJ
Rev Med Liege; 2000 Jul; 55(7):751-3. PubMed ID: 11014111
[TBL] [Abstract][Full Text] [Related]
9. Ibuprofen-induced aseptic meningitis in rheumatoid arthritis.
Horn AC; Jarrett SW
Ann Pharmacother; 1997 Sep; 31(9):1009-11. PubMed ID: 9296242
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib.
Konstam MA; Weir MR; Reicin A; Shapiro D; Sperling RS; Barr E; Gertz BJ
Circulation; 2001 Nov; 104(19):2280-8. PubMed ID: 11696466
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone).
Reicin AS; Shapiro D; Sperling RS; Barr E; Yu Q
Am J Cardiol; 2002 Jan; 89(2):204-9. PubMed ID: 11792343
[TBL] [Abstract][Full Text] [Related]
12. [Results of the VIGOR study. Rofecoxib halves the complication rate].
MMW Fortschr Med; 2001 Jun; 143(23):35. PubMed ID: 11460417
[No Abstract] [Full Text] [Related]
13. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.
Lisse JR; Perlman M; Johansson G; Shoemaker JR; Schechtman J; Skalky CS; Dixon ME; Polis AB; Mollen AJ; Geba GP;
Ann Intern Med; 2003 Oct; 139(7):539-46. PubMed ID: 14530224
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
Wolfe F; Zhao S; Pettitt D
J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
[TBL] [Abstract][Full Text] [Related]
16. Leflunomide-induced aseptic meningitis.
Cohen JD; Jorgensen C; Sany J
Joint Bone Spine; 2004 May; 71(3):243-5. PubMed ID: 15182800
[TBL] [Abstract][Full Text] [Related]
17. Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study.
Hawkey CJ; Laine L; Simon T; Quan H; Shingo S; Evans J;
Gut; 2003 Jun; 52(6):820-6. PubMed ID: 12740337
[TBL] [Abstract][Full Text] [Related]
18. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Langman MJ; Jensen DM; Watson DJ; Harper SE; Zhao PL; Quan H; Bolognese JA; Simon TJ
JAMA; 1999 Nov; 282(20):1929-33. PubMed ID: 10580458
[TBL] [Abstract][Full Text] [Related]
19. Selective COX-2 inhibition.
Silas S; Clegg DO
Bull Rheum Dis; 1999; 48(2):1-4. PubMed ID: 12024416
[No Abstract] [Full Text] [Related]
20. [Rofecoxib: its efficacy in rheumatoid arthritis and acute pain].
Morović-Vergles J
Reumatizam; 2003; 50(2):47-8. PubMed ID: 15098376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
